SPOTLIGHT: Obesity scrips top 1 million in Britain

Use of obesity drugs in Britain is up eightfold in the last seven years, to more than 1 million prescriptions; the two most popular weight-loss drugs there are orlistat (sold as Xenical by Roche) and sibutramine (sold as Reductil by Abbott Laboratories). Report | Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.